BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20186482)

  • 1. Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice.
    Huang EH; Johnson LA; Eaton K; Hynes MJ; Carpentino JE; Higgins PD
    Dig Dis Sci; 2010 Nov; 55(11):3086-94. PubMed ID: 20186482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
    Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
    Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS
    Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins have biphasic effects on angiogenesis.
    Weis M; Heeschen C; Glassford AJ; Cooke JP
    Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.
    Yang Z; Xiao H; Jin H; Koo PT; Tsang DJ; Yang CS
    Int J Cancer; 2010 Feb; 126(4):852-63. PubMed ID: 19626588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
    Ajith TA; Anu V; Riji T
    J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
    Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
    Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.
    Sarrabayrouse G; Synaeve C; Leveque K; Favre G; Tilkin-Mariamé AF
    Neoplasia; 2007 Dec; 9(12):1078-90. PubMed ID: 18084615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.
    Pereira MA; Warner BM; Knobloch TJ; Weghorst CM; Lubet RA; Steele VE; Casto BC
    Int J Cancer; 2012 Sep; 131(6):1277-86. PubMed ID: 22161747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine and atorvastatin exert protective and additive effects via antiapoptotic and antiautophagic mechanisms after transient middle cerebral artery occlusion in Zucker metabolic syndrome rats.
    Zhang X; Deguchi S; Deguchi K; Ohta Y; Yamashita T; Shang J; Tian F; Liu N; Liu W; Ikeda Y; Matsuura T; Abe K
    J Neurosci Res; 2011 Aug; 89(8):1228-34. PubMed ID: 21538457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
    Weber MS; Prod'homme T; Youssef S; Dunn SE; Steinman L; Zamvil SS
    J Neuroinflammation; 2014 Feb; 11():29. PubMed ID: 24498870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression.
    Xu Y; Zhou S; Fang Z; Li X; Huang D; Liu Q; Zheng C
    Pharm Biol; 2014 Sep; 52(9):1196-203. PubMed ID: 25116077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Finlay GA; Malhowski AJ; Polizzi K; Malinowska-Kolodziej I; Kwiatkowski DJ
    Mol Cancer Ther; 2009 Jul; 8(7):1799-807. PubMed ID: 19584242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X; Cui XX; Avila GE; Huang MT; Liu Y; Patel J; Kong AN; Paulino R; Shih WJ; Lin Y; Rabson AB; Reddy BS; Conney AH
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.
    Bustos C; Hernández-Presa MA; Ortego M; Tuñón J; Ortega L; Pérez F; Díaz C; Hernández G; Egido J
    J Am Coll Cardiol; 1998 Dec; 32(7):2057-64. PubMed ID: 9857893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
    Aktas O; Waiczies S; Smorodchenko A; Dorr J; Seeger B; Prozorovski T; Sallach S; Endres M; Brocke S; Nitsch R; Zipp F
    J Exp Med; 2003 Mar; 197(6):725-33. PubMed ID: 12629065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
    J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on the different phases of atherogenesis.
    Rubba P
    Drugs; 2007; 67 Suppl 1():17-27. PubMed ID: 17910518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.